Topoisomerase I inhibition by the camptothecin analog Gl147211C - From the laboratory to the clinic

被引：15

作者：

Besterman, JM ^{[1
]}

机构：

[1] GLAXO RES LABS, DEPT CELL BIOL, RES TRIANGLE PK, NC 27709 USA

来源：

CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT | 1996年 / 803卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb26389.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：202 / 209

页数：8

共 13 条

[1]

EMERSON DL, 1995, CANCER RES, V55, P603

[2] A PHASE-II STUDY OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, FOR PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER [J].

FUKUOKA, M ;

NIITANI, H ;

SUZUKI, A ;

MOTOMIYA, M ;

HASEGAWA, K ;

NISHIWAKI, Y ;

KURIYAMA, T ;

ARIYOSHI, Y ;

NEGORO, S ;

MASUDA, N ;

NAKAJIMA, S ;

TAGUCHI, T ;

ASAKAWA, M ;

NAKABAYASI, T ;

NAKAI, T ;

KURITA, Y ;

KINAMERI, K ;

NOMURA, K ;

NAGAO, K ;

SAIJO, N ;

OHE, Y ;

SUGIURA, T ;

SHIMOKATA, K ;

SAKA, H ;

NEGORO, S ;

NAKAJIMA, S ;

TOHDA, Y ;

FUJII, M ;

OTA, M ;

HARA, N ;

HARA, Y ;

FUJISAWA, K ;

NAKANO, S ;

ARAKI, J ;

NIITANI, H ;

MIYATA, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :16-20

[3] DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].

GIOVANELLA, BC ;

STEHLIN, JS ;

WALL, ME ;

WANI, MC ;

NICHOLAS, AW ;

LIU, LF ;

SILBER, R ;

POTMESIL, M .

SCIENCE, 1989, 246 (4933) :1046-1048

[4]

GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461

[5] SYNTHESIS AND ANTITUMOR-ACTIVITY OF NOVEL WATER-SOLUBLE DERIVATIVES OF CAMPTOTHECIN AS SPECIFIC INHIBITORS OF TOPOISOMERASE-I [J].

LUZZIO, MJ ;

BESTERMAN, JM ;

EMERSON, DL ;

EVANS, MG ;

LACKEY, K ;

LEITNER, PL ;

MCINTYRE, G ;

MORTON, B ;

MYERS, PL ;

PEEL, M ;

SISCO, JM ;

STERNBACH, DD ;

TONG, WQ ;

TRUESDALE, A ;

UEHLING, DE ;

VUONG, A ;

YATES, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (03) :395-401

[6]

MUGGIA FM, 1972, CANCER CHEMOTH REP 1, V56, P515

[7] NOVEL A-RING MODIFIED CAMPTOTHECINS AS TOPOISOMERASE-I INHIBITORS [J].

PEEL, MR ;

MILSTEAD, MW ;

STERNBACH, DD ;

BESTERMAN, JM ;

LEITNER, P ;

MORTON, B ;

WALL, ME ;

WANI, MC .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (18) :2129-2132

[8]

PLUMB JA, 1989, CANCER RES, V49, P4435

[9] PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR [J].

ROWINSKY, EK ;

GROCHOW, LB ;

HENDRICKS, CB ;

ETTINGER, DS ;

FORASTIERE, AA ;

HUROWITZ, LA ;

MCGUIRE, WP ;

SARTORIUS, SE ;

LUBEJKO, BG ;

KAUFMANN, SH ;

DONEHOWER, RC .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :647-656

[10]

SAWADA S, 1991, CHEM PHARM BULL, V39, P1446

← 1 2 →